v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 10,348 $ 9,491
Fixed maturity securities (amortized cost of $26,806 and $25,773; allowance for credit losses of $60 and $21) 25,347 25,884
Equity securities 2,151 740
Premium receivables, net 10,686 10,073
Self-funded receivables, net 6,277 5,162
Other receivables 7,610 6,307
Other current assets 6,105 5,344
Total current assets 68,524 63,001
Long-term investments:    
Fixed maturity securities (amortized cost of $1,272 and $1,116; allowance for credit losses of $$0 and $0) 1,211 1,121
Other invested assets 11,508 10,839
Property and equipment, net 4,613 4,679
Goodwill 28,343 28,344
Other intangible assets 10,877 11,200
Other noncurrent assets 2,725 2,310
Total assets 127,801 121,494
Current liabilities:    
Medical claims payable 18,438 17,084
Other policyholder liabilities 2,635 3,632
Unearned income 1,637 1,493
Accounts payable and accrued expenses 8,315 7,322
Short-term borrowings 0 150
Current portion of long-term debt 375 1,099
Other current liabilities 15,262 10,255
Total current liabilities 46,662 41,035
Long-term debt, less current portion 30,382 30,797
Deferred tax liabilities, net 1,487 2,110
Other noncurrent liabilities 4,476 3,526
Total liabilities 83,007 77,468
Commitments and contingencies – Note 10
Shareholders’ equity    
Preferred stock, without par value, shares authorized 100,000,000; shares issued and outstanding – none 0 0
Common stock, par value $0.01, shares authorized 900,000,000; shares issued and outstanding – 216,113,946 and 220,723,898 2 2
Additional paid-in capital 8,987 8,938
Retained earnings 37,368 35,393
Accumulated other comprehensive loss (1,676) (451)
Total shareholders’ equity 44,681 43,882
Noncontrolling interests 113 144
Total equity 44,794 44,026
Total liabilities and equity $ 127,801 $ 121,494